SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel–gemcitabine as first-line chemotherapy for ovarian cancer

The feasibility of sequential carboplatin followed by docetaxel-based therapy for untreated ovarian cancer was determined. Patients received four q3w cycles of carboplatin AUC 7, then four q3w cycles of either docetaxel 100 mg m(−2) (day 1) (arm A); docetaxel 75 mg m(−2) (day 8) and gemcitabine 1250...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vasey, P A, Atkinson, R, Osborne, R, Parkin, D, Symonds, R, Paul, J, Lewsley, L, Coleman, R, Reed, N S, Kaye, S, Rustin, G J S
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2006
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361073/
https://ncbi.nlm.nih.gov/pubmed/16404361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602909
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items